Iron Prehabilitation in Endometrial Cancer
Conditions: Endometrial Cancer; Perioperative Complication; Prehabilitation Interventions: Drug: Ferrous Gluconate 300 MG Sponsors: National and Kapodistrian University of Athens Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor
Conditions: Advanced Solid Tumor; Lung Cancer; Pancreas Cancer; Breast Cancer; Thyroid Cancer; Colorectal Cancer; Cervical Cancer; Ovarian Cancer; Vulva Cancer Interventions: Drug: CNSI-Fe(II) 30 mg; Drug: CNSI-Fe(II) 60 mg; Drug: CNSI-Fe(II) 90 mg Sponsor: Sichuan Enray Pharmaceutical Sciences Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera
WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 20, 2023 Category: Pharmaceuticals Source Type: clinical trials
Scoliosis Iron Supplementation Study
Conditions: Adolescent Idiopathic Scoliosis; Neuromuscular Scoliosis; Perioperative/Postoperative Complications; Iron Deficiencies; Anemia; Spinal Fusion; Postoperative Cognitive Dysfunction Interventions: Dietary Supplement: Oral ferrous sulfate; Dietary Supplement: Oral placebo tablet Sponsors: Columbia University; National Institute of General Medical Sciences (NIGMS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
